KRR1
KRR1 small subunit processome component homolog
Also known as: HRB2, KRR1_HUMAN, RIP-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13601
- Gene
- KRR1
- Ensembl
- ENSG00000111615
- Chromosome
- 12
- Canonical length
- 381 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome
OverviewNCBI Gene
Enables RNA binding activity. Involved in ribosomal small subunit biogenesis. Located in chromosome; intercellular bridge; and nuclear lumen. Part of small-subunit processome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
381 residues, UniProt reviewed canonical sequence.
>Q13601|KRR1
1 MASPSLERPE KGAGKSEFRN QKPKPENQDE SELLTVPDGW KEPAFSKEDN PRGLLEESSF
61 ATLFPKYREA YLKECWPLVQ KALNEHHVNA TLDLIEGSMT VCTTKKTFDP YIIIRARDLI
121 KLLARSVSFE QAVRILQDDV ACDIIKIGSL VRNKERFVKR RQRLIGPKGS TLKALELLTN
181 CYIMVQGNTV SAIGPFSGLK EVRKVVLDTM KNIHPIYNIK SLMIKRELAK DSELRSQSWE
241 RFLPQFKHKN VNKRKEPKKK TVKKEYTPFP PPQPESQIDK ELASGEYFLK ANQKKRQKME
301 AIKAKQAEAI SKRQEERNKA FIPPKEKPIV KPKEASTETK IDVASIKEKV KKAKNKKLGA
361 LTAEEIALKM EADEKKKKKK KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KRR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 41 nTPM
- skeletal muscle: 22 nTPM
- tongue: 21 nTPM
- liver: 19 nTPM
- parathyroid gland: 19 nTPM
- salivary gland: 18 nTPM
Single-cell type
- oocytes: 198 nCPM
- erythrocyte progenitors: 129 nCPM
- urothelial cells: 120 nCPM
- megakaryocytes: 118 nCPM
- thymic myoid cells: 117 nCPM
- esophageal apical cells: 107 nCPM
Immune cell
- memory B-cell: 23 nTPM
- naive B-cell: 21 nTPM
- naive CD4 T-cell: 19 nTPM
- memory CD4 T-cell: 18 nTPM
- T-reg: 18 nTPM
- naive CD8 T-cell: 18 nTPM
Brain region
- cerebellum: 15 nTPM
- hypothalamus: 13 nTPM
- white matter: 12 nTPM
- cerebral cortex: 11 nTPM
- choroid plexus: 11 nTPM
- spinal cord: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- -1.09
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- K Homology domain
- K Homology domain, type 1 superfamily
- Ribosomal RNA assembly KRR1
- KRR1 small subunit processome component, first KH domain
- KRR1 small subunit processome component, second KH domain
- KRR1 small subunit processome component, second KH domain, eukaryotes
- KRR1 small subunit processome component, first KH domain, eukaryotes
- Krr1 KH1 domain
- KRR1 small subunit processome component, second KH domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KRR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KRR1 as an antibody target. Whether an autoantibody or antibody against KRR1 could matter depends on whether native KRR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KRR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KRR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...